RxDoctor Payments Data

Brianna Myers, PA

Physician Assistant · Arvin, CANPI 1508276098

Payments from drug & device makers

$640in general payments, 2019–2025

Across 33 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$104
  • GSK$69
  • Merck$66
  • Shield Therapeutics Inc$61
  • Pfizer$51
  • Gilead$49
  • plus $241 from 8 others

What the payments were for

  • Food & beverage$640100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$640 in reported general payments places this provider in the 65th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$400
Medicare patients
14
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin184$163,466
JanuviaSitagliptin Phosphate51$50,701
TradjentaLinagliptin76$49,324
Metformin Er GastricMetformin Hcl15$38,032
TrulicityDulaglutide36$34,428
OzempicSemaglutide25$22,039
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,423
Diclofenac Sodium17$8,564
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$6,475
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$5,488
EliquisApixaban12$3,637
LantusInsulin Glargine,hum.Rec.Anlog19$2,587
Rosuvastatin Calcium145$2,520
Atorvastatin Calcium297$2,442
Albuterol Sulfate HfaAlbuterol Sulfate47$1,493

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$66$50,70151 claims
Lilly USA, LLCTrulicity$104$34,42836 claims
Novo NordiskOzempic$28$22,03925 claims
GSKTrelegy Ellipta$69$14,42317 claims
PfizerEliquis$51$3,63712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Arvin

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →